Strategic partnership WellDyne is actively expanding through collaborations, evidenced by the May 2025 partnership with Waltz Health to deliver a transparent specialty pharmacy solution. Sales opportunities exist in offering integrative pricing, distribution, and prescribing workflows that leverage Waltz Connect and WellDyne’s PBM capabilities for high cost specialties.
Specialty focus The company emphasizes engagement in the high-cost specialty pharmacy space and uses analytics and personalized engagement to improve outcomes. Target opportunities include scaling specialty medication programs, value-based pricing discussions, and implementable patient engagement strategies with pharmaceutical partners.
Technology leverage WellDyne deploys a modern tech stack (Airflow, DBT, Azure, analytics tooling, and automation) and partners with tech-forward firms. Sales opportunities include offering advanced data analytics, pricing analytics, and API-enabled integrations to streamline client operations and reporting.
Industry credibility With URAC accreditations and recognition as a Best Place to Work, WellDyne demonstrates stability and performance. Use this credibility in conversations with prospective clients seeking proven PBM partners with regulated, compliant operations and strong workforce stability.
Growth and leadership Leadership transition to Stephen Saft as CEO and the HealthDyne expansion signal an evolving operating model beyond traditional PBMs. Opportunities exist to position WellDyne as a partner for integrated healthcare programs, pharmacy services extensions, and broader administrative services for health systems.